MAPK3 and breast carcinoma: Additionally, a quantitative proteomics analysis of CY-9d-treated breast cancer cells revealed some potential Raf1 and ERK1 interacting proteins in breast cancer cells, such as HSP90, PAK4 and RAB2A [39-46].